Petauri Kinect, formerly known as The Kinetix Group—Powered by Petauri, is a strategic consultancy and marketing agency. We partner with medical and commercial teams to engage stakeholders across health systems, integrated delivery networks, and hospitals. At Petauri Kinect, we focus on creating bespoke and scalable engagement solutions that optimize therapeutic access for patients.
For more information about Petauri Kinect, contact us at info@petauri.com or visit www.petauri.com.
In today's healthcare landscape, previous account planning strategies and tactics don't work. Our latest product, PACT, allows users to create improved outcomes and mutual success for their customers.
PACT is an insight-driven platform that helps life science organizations transform how they engage with their health system customers. This multilayered product offering leverages insights and resources developed in Kinect's capacity as a full-service healthcare agency and consultancy.
Benefits include:
-Customer engagement audit
-Library of account excellence resources
-Disease-specific advisory support
PACT is our commitment to our customers to help them drive sustainable change for patients, providers, payers and pharma.
Heading to World EPA? Let's Connect!
Petauri and our colleagues at Mtech Access will be at the World Evidence, Pricing, and Access Congress on March 5-6. Stop by booth 48 to learn more about how we can support your access goals. We look forward to meeting you!
🔗 Want to schedule a meeting ahead of time? Visit: https://lnkd.in/gSijvxSa#WorldEPA#Pricing#MarketAccess#Evidence#HealthcareInnovation
Petauri Kinect is proud to have colleagues like Mindy Olivarez who are passionate about learning the complexities of the health system landscape, translating value across the care continuum and ensuring access to high-quality, affordable healthcare for everyone.
Read more about Mindy's career journey and her expertise as a Petauri ACE Team member below!
Real-world insights from real-world experience—that's what The Petauri™ ACE team, our internal collective of former access decision-makers hailing from influential US payers, health systems, and policy organizations, bring to every client engagement. We are excited to shine a spotlight on these individuals and share more about how their first-hand experience can support your access goals.
Meet Mindy Olivarez, the Senior Vice President of Care Delivery and Network of Excellence Strategic Lead at Petauri Kinect. With 25 years of dedicated service in healthcare, Mindy has spearheaded numerous initiatives focused on enhancing the patient and provider experience. Her impressive career includes managing primary care clinics, launching pioneering value-based care programs, and driving growth strategies for a major Integrated Delivery Network.
Mindy's passion for bridging gaps between diverse players in the healthcare sector led her to co-develop Petauri Kinect's innovative Networks of Excellence model. These networks collaborate with over 85 health systems nationwide to promote the adoption of evidence-based guidelines and improve health outcomes through the implementation of care pathways.
🔗 Curious about how Petauri’s ACE team can transform your health system strategy? Visit www.Petauri.com/ACE to learn more or contact us at www.petauri.com/contact#PetauriACE#Healthsystems#MarketAccess#HealthcareInnovation
🔔 I'm excited to announce the Women's Health research Collaborative and Avana Health have launched a joint initiative to raise awareness for acute heavy menstrual bleeding (HMB).
🩸 "The clinical problem of Acute HMB has received little attention despite the adverse impact on the lives of millions of women and the costs incurred by our healthcare systems," said Malcolm Munro, MD, FACOG, FRCSC, clinical professor at UCLA and co-founder of the WHrC.
💡At Avana Health, we appreciate working with value and mission aligned partners like WHrC, which is a global initiative focused on working with multistakeholder partners to identify gaps in women's health care and address unmet need.
📄 We're in the process of publishing our first white paper together. As Avana Health advances its treatment for Acute HMB through clinical trials.
https://lnkd.in/eWfrwpvRPetauri Kinect Mindy Olivarez Sarah O'Brien, MDPamela DyneAngela Morehead, DNP, FNP, C-EFMMichael RoyalsJohn Morehead, MD, FACOG#womenshealth#femtech
New partnership!
Women’s Health research Collaborative (WHrC) announced its new initiative with Avana Health around Acute Heavy Menstrual Bleeding (HMB).
According to FIGO (International Federation of Gynecology and Obstetrics) and American College of Obstetricians and Gynecologists (ACOG), Acute HMB is “an episode of heavy uterine bleeding in the reproductive years, unrelated to pregnancy, that, in the opinion of the clinician, is of sufficient quantity to require immediate intervention.”
The goal of this collaboration is to improve the care for affected girls and women by raising awareness of the condition through
-Improved education
-Research
-Development of effective interventions
Read the full press release here > https://lnkd.in/ecNCfChV
Access resources around women’s health best practices and care pathways here > https://lnkd.in/dzMT96Z4
WHrC is part of Petauri Kinect’s Networks of Excellence. Discover how these networks are helping to advance care delivery at https://lnkd.in/e2bzP6eT
Today’s Petauri Kinect 3-minute Executive Briefing topic is the Startling Growth of Illegal Online Pharmacies.
The IQVIA Institute reported in 2023 that there were 15,501 Illegal Online Pharmacies (IOP’s), collectively selling approximately 85 million illegal prescriptions, with an estimated value of $34 billion. At the time of the study, these IOP’s were actively marketing 70% (5,085) of the 7,310 legally prescribed medicines dispensed to patients in the USA.
The study reported that drugs sold through IOPs are estimated to create 10 times higher adverse event rates than drugs sold through legal pharmacies. These adverse events represent an estimated additional $67 billion dollars in direct healthcare costs for the U.S. healthcare system, in addition to the healthcare consequences for the patients who used them.
Need more information? Or have suggestions for topics of interest? Please reach out with an email to Insights@Petauri.com
Check out Petauri‘s growing library of Executive Briefings where you can listen and download the companion PDF infographics.
https://lnkd.in/evZKhgre#Petauri, #PetauriKinect, #PetauriMax, #PetauriPACT, #Market_Access, #TKG, #TKGPACT, #Illegal_Online_Pharmacies, #IOP, #Specialty_Pharmacy, #Medication, #Pharma, #Industry
Clinical trials are becoming more complex 🚨
According to Scientific Reports, the average complexity score across all trials has increased by more than 10 percentage points, from the low-30s to the mid-40s, over the past ten years.
Understanding the nuances of health system infrastructure can help life science companies design and implement better clinical trials.
Read the third installment in our immersion article series to learn how > https://lnkd.in/dbiBF8n3
Curious how Petuari Kinect can help retool your immersion strategy? Contact us through our LinkedIn inbox or visit https://lnkd.in/e3W7mCf6#clinicaltrials#healthsystems#immersion#infrastructure
Media alert! 🔔
Petauri Kinect was featured in PM360 Magazine 2024 Innovators.
Each year, PM360 releases an issue focused on the latest innovations in the healthcare industry from life science to marketing.
The article profiles Petauri Kinect's growing network of leading health systems, allowing our clients to leverage real-time access to the customer voice.
Our Networks of Excellence offers:
-180K providers influencing points of care
-350 stakeholders working across market channels
-71 organizations driving real world evidence
Read the full article here > https://lnkd.in/eJNCPskJ
Curious how Petauri Kinect can help retool your health system strategy?
Contact us at https://lnkd.in/eadTaaSM
We are thrilled to announce that Petauri has been featured in PM360 Magazine's Innovation Issue—the life sciences marketing industry’s go-to guide for the latest advancements. This feature highlights how Petauri MAx and Petauri Kinect leverage first-hand experience and real-world insights through our collective of subject matter experts to create tailored, data-driven solutions that enhance decision-making and optimize access.
At Petauri, innovation is at the core of what we do. Our goal is to create strategies and solutions that truly move the needle for health systems, providers, and patients, accelerating access to life-changing healthcare innovations. We are honored to be recognized as one of this year’s innovators.
🔗 Check out the full feature here: https://lnkd.in/eJNCPskJ
🔗 Learn more about how our ACE team is driving innovation here: https://petauri.com/ace#HealthcareInnovation#MarketAccess#Insights#PetauriACE#Pharma
Introducing Petauri's Access Customer Experience ("ACE") team!
This team of experts represents former access decision-makers from influential US health systems, payers and policy organizations.
With 80% of health care providers now employed by hospitals or corporate entities, our ACE team can empower life science companies to engage with these consolidated and centralized decision-makers.
Interested in retooling your health system strategy? Visit www.petauri.com/contact
We are excited to unveil our ACE team—an internal powerhouse of industry experts and former access decision-makers. With experience across all lines of business, including Medicare, Medicaid, and Commercial, the ACE team will integrate their expertise into every client engagement, reaffirming Petauri’s commitment to providing comprehensive support and driving successful access outcomes for our clients.
From pricing and reimbursement to stakeholder engagement and policy navigation, the ACE team offers practical, tailored guidance to meet diverse stakeholder needs.
Interested in learning more?
🔗 Meet the ACE team: https://petauri.com/ACE/
🔗 Read the full press release: https://lnkd.in/eUDMaiyK#MarketAccess#HealthcareInnovation#PetauriACE#IndustryExperts
Did you know more than 70% of healthcare administrators and professionals say health systems hold as much—if not more—influence as payers when it comes to prescribing oncology regimens?
In the December issue of Pharmaceutical Executive, Formulary Insights—Powered by Petauri's Kevin Tse, PharmD and Joe Rossi IV, MHA highlight how Integrated Delivery Networks (IDNs) and health systems are becoming pivotal players in drug utilization and the implications this has for securing optimal market access.
🔗 Read the full article here: https://lnkd.in/eGT7nhEj . To understand how Petauri can support your market access goals, contact us today www.petauri.com/contact#HealthSystems#MarketAccess#HealthcareInnovation
Wishing all of our clients, partners, colleagues, and friends a Happy New Year. As we step into 2025, we are excited about the opportunities and innovations that lie ahead.
This year, we are committed to pushing the boundaries of what's possible and continuing to bridge the gap between groundbreaking therapies and the complex healthcare ecosystem to ensure that innovative therapies reach the patients who need them most.
Cheers to a transformative year ahead!
#HealthcareInnovation#MarketAccess#HEOR#HealthEconomics#Medcomms